Boston Therapeutics Inc.
Boston Therapeutics Inc.
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
|
June 28, 2016
|
CJY Holdings Limited
00 Xxxxxxx Xxx Xxxx
Xxxxxxx Xxx, Xxxx Xxxx
Re: | Securities Purchase Agreement dated September 24, 2015 (the “SPA”) by and between Boston Therapeutics Inc. and CJY Holdings Limited, as amended |
Gentlemen:
Reference is hereby made to the SPA. By executing this letter, the undersigned investor agrees that the offering amount shall be increased from $1,702,000 to $1,752,000. Accordingly, it is hereby agreed to by the parties that Section 1(d) of the Agreement shall be amended and restated to state the following:
"d. Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
We kindly request that you execute this letter below indicating that you agree with the above amendment.
|
Sincerely,
Boston Therapeutics Inc.
By: /s/ Xxxxxx Xxx-Xxxx Xxxxx
Name: Xxxxxx Xxx-Xxxx Xxxxx
Title: Interim CEO
|
AGREED AND ACKNOWLEDGED:
CJY Holdings Limited
By: /s/ Xxxxx Xxx Him
Name: Xxxxx Xxx Him
Title: